NCT05825651

Brief Summary

The Peking University Health Cohort in Anning, Yunnan (PKUHC-AN) is a prospective cohort study carried out in Anning, Yunnan. The primary aim of this study is to investigate the impact of COVID-19 on older adults' health, and to provide high-quality evidence of real world research for the optimization of prevention and control strategies of COVID-19 and other emerging infectious diseases. Data will be collected regarding health status, history of COVID-19 infections and vaccines, lifestyle and socioeconomic characteristics, as well as the short- and long-term health outcomes.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11,527

participants targeted

Target at P75+ for all trials

Timeline
4mo left

Started Apr 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Apr 2023Aug 2026

First Submitted

Initial submission to the registry

March 26, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

April 24, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

April 24, 2023

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

December 12, 2024

Status Verified

December 1, 2024

Enrollment Period

3.3 years

First QC Date

March 26, 2023

Last Update Submit

December 7, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of long COVID

    The proportion of participants incurred any symptoms or diagnosed diseases of post-COVID in all infected participants.

    From baseline until the date of long COVID symptoms or date of death from any cause, whichever came first, assessed up to 12 months.

Secondary Outcomes (6)

  • Reinfection incidence of COVID-19

    At 3 months, 6 months, 9 months, 1 year after baseline investigation.

  • Cognitive impairment

    At 3 months, 6 months, 9 months, 1 year after baseline investigation.

  • Depression

    At 3 months, 6 months, 9 months, 1 year after baseline investigation.

  • Medical expenditure

    At 3 months, 6 months, 9 months, 1 year after baseline investigation.

  • Incidence of catastrophic health expenditure

    At 3 months, 6 months, 9 months, 1 year after baseline investigation.

  • +1 more secondary outcomes

Study Arms (2)

Exposure group

Group with history of COVID-19 infections and vaccines, as well as health-related, behavioral, socioeconomic exposures.

Other: no interventions

Non-exposure group

Group without history of COVID-19 infections and vaccines, as well as health-related, behavioral, socioeconomic exposures.

Interventions

This is an observational study without any intervention.

Exposure group

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Older adults aged at least 60 years old living in Anning, Yunnan, China

You may qualify if:

  • \. ≥60 years
  • \. Resided in Anning in the past half year and have no plan to move out in next 1 year
  • \. Older adults who are willing to participate in this study with informed consent

You may not qualify if:

  • \. Unable to answer questions or communicate
  • \. Older adults who are not willing to participate in this study or without informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anning medical community

Kunming, Yunan, China

Location

MeSH Terms

Conditions

Post-Acute COVID-19 SyndromeCOVID-19Reinfection

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsRecurrence

Study Officials

  • Jue Liu, Ph.D

    Peking University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

March 26, 2023

First Posted

April 24, 2023

Study Start

April 24, 2023

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

December 12, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations